<H1>Chapter DOI: 10.1186/s13046-016-0369-0<br/>Cited-By Count: 0</H1><table border="1" width="30%"><tr><td>Total References</td><td>60</td></tr><tr><td>Springer references</td><td>7</td></tr><tr><td>Non Springer references</td><td>53</td></tr><tr><td>BibStructured Count</td><td width="10%">56</td></tr><tr><td>BibUnstructured Count</td><td width="10%">4</td></tr><tr><td>DOI already available in SpringerLink</td><td>38</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>12</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>1</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>3</td></tr><tr><td>DOI Obtained For Non Springer</td><td>10</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>10</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>3</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:2.</td><td><a href=http://dx.doi.org/10.3322/caac.21262>10.3322/caac.21262</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011;378:9791.</td><td><a href=http://dx.doi.org/10.1016/S0140-6736(10)62307-0>10.1016/S0140-6736(10)62307-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Andrianifahanana M, Moniaux N, Schmied BM, Ringel J, Friess H, Hollingsworth MA, Buchler MW, Aubert JP and Batra SK. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clin Cancer Res. 2001;7:12.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Zhi X, Tao J, Xie K, Zhu Y, Li Z, Tang J, Wang W, Xu H, Zhang J and Xu Z. MUC4-induced nuclear translocation of beta-catenin: a novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer. Cancer Lett. 2014;346:1.</td><td><a href=http://dx.doi.org/10.1016/j.canlet.2013.12.021>10.1016/j.canlet.2013.12.021</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Workman HC, Sweeney C, Carraway 3rd KL. The membrane mucin Muc4 inhibits apoptosis induced by multiple insults via ErbB2-dependent and ErbB2-independent mechanisms. Cancer Res. 2009;69:7.</td><td><a href=http://dx.doi.org/10.1158/0008-5472.CAN-08-2089>10.1158/0008-5472.CAN-08-2089</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Bafna S, Kaur S, Momi N, Batra SK. Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin. Br J Cancer. 2009;101:7.</td><td><a href=http://dx.doi.org/10.1038/sj.bjc.6605285>10.1038/sj.bjc.6605285</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Ponnusamy MP, Lakshmanan I, Jain M, Das S, Chakraborty S, Dey P, Batra SK. MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells. Oncogene. 2010;29:42.</td><td><a href=http://dx.doi.org/10.1038/onc.2010.309>10.1038/onc.2010.309</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Chaturvedi P, Singh AP, Moniaux N, Senapati S, Chakraborty S, Meza JL, Batra SK. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins. Mol Cancer Res. 2007;5:4.</td><td><a href=http://dx.doi.org/10.1158/1541-7786.MCR-06-0353>10.1158/1541-7786.MCR-06-0353</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Ponnusamy MP, Singh AP, Jain M, Chakraborty S, Moniaux N, Batra SK. MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells. Br J Cancer. 2008;99:3.</td><td><a href=http://dx.doi.org/10.1038/sj.bjc.6604517>10.1038/sj.bjc.6604517</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Singh AP, Moniaux N, Chauhan SC, Meza JL, Batra SK. Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis. Cancer Res. 2004;64:2.</td><td><a href=http://dx.doi.org/10.1158/0008-5472.CAN-03-2636>10.1158/0008-5472.CAN-03-2636</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, Year, ArticleTitle, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Mimeault M, Johansson SL, Senapati S, Momi N, Chakraborty S, Batra SK. MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies. Cancer Lett. 2010;295:1.</td><td><a href=http://dx.doi.org/10.1016/j.canlet.2010.02.015>10.1016/j.canlet.2010.02.015</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Li G, Zhao L, Li W, Fan K, Qian W, Hou S, Wang H, Dai J, Wei H and Guo Y. Feedback activation of STAT3 mediates trastuzumab resistance via upregulation of MUC1 and MUC4 expression. Oncotarget. 2014;5:18.</td><td><a href=http://dx.doi.org/10.18632/oncotarget.2135>10.18632/oncotarget.2135</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, Author_FamilyName_1, Author_FamilyName_2, JournalTitle, Year, VolumeID</td><td>CrossRef</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Skrypek N, Duche&#710;ne B, Hebbar M, Leteurtre E, van Seuningen I, Jonckheere N. The MUC4 mucin mediates gemcitabine resistance of humanpancreatic cancer cells via the Concentrative Nucleoside Transporter family. Oncogene. 2013;32:13.</td><td><a href=http://dx.doi.org/10.1038/onc.2012.179>10.1038/onc.2012.179</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Biamonti</span> <span style='background:#DDDDDD'>G</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Catillo</span> <span style='background:#DDDDDD'>M</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Pignataro</span> <span style='background:#DDDDDD'>D</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Montecucco</span> <span style='background:#DDDDDD'>A</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Ghigna</span> <span style='background:#DDDDDD'>C.</span></span></aug> <span style='background:#CCCCFF'>The alternative splicing side of cancer</span>. <span style='background:#CCFF99'>Semin Cell Dev Biol</span>. <span style='background:#66FF66'>2014</span>. <span style='background:#FFFF0F'>doi:10.1016/j. semcdb</span>.</td><td><a href=http://dx.doi.org/10.1016/j.semcdb.2014.03.016>10.1016/j.semcdb.2014.03.016</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, Author_FamilyName_2, Author_FamilyName_1, ArticleTitle</td><td>CrossRef</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Neeb A, Hefele S, Bormann S, Parson W, Adams F, Wolf P, Miernik A, Schoenthaler M, Kroenig M, Wilhelm K, Schultze-Seemann W, Nestel S, Schaefer G, Bu H, Klocker H, Nazarenko I, et al. Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer. Oncotarget. 2014;5:18.</td><td><a href=http://dx.doi.org/10.18632/oncotarget.2365>10.18632/oncotarget.2365</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Escande F, Lemaitre L, Moniaux N, Batra SK, Aubert JP, Buisine MP. Genomic organization of MUC4 mucin gene. Towards the characterization of splice variants. Eur J Biochem. 2002;269:15.</td><td><a href=http://dx.doi.org/10.1046/j.1432-1033.2002.03032.x>10.1046/j.1432-1033.2002.03032.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Chaturvedi P, Singh AP, Batra SK. Structure, evolution, and biology of the MUC4 mucin. FASEB J. 2008;22:4.</td><td><a href=http://dx.doi.org/10.1096/fj.07-9673rev>10.1096/fj.07-9673rev</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, Author_FamilyName_2, Author_FamilyName_1, VolumeID</td><td>CrossRef</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Choudhury A, Moniaux N, Winpenny JP, Hollingsworth MA, Aubert JP, Batra SK. Human MUC4 mucin cDNA and its variants in pancreatic carcinoma. J Biochem. 2000;128:2.</td><td><a href=http://dx.doi.org/10.1093/oxfordjournals.jbchem.a022746>10.1093/oxfordjournals.jbchem.a022746</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Choudhury A, Moniaux N, Ringel J, King J, Moore E, Aubert JP, Batra SK. Alternative splicing at the 3&#8242;-end of the human pancreatic tumor-associated mucin MUC4 cDNA. Teratog Carcinog Mutagen. 2001;21:1.</td><td><a href=http://dx.doi.org/10.1002/1520-6866(2001)21:1&lt;83::AID-TCM8&gt;3.0.CO;2-3>10.1002/1520-6866(2001)21:1&lt;83::AID-TCM8&gt;3.0.CO;2-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Andrianifahanana M, Moniaux N, Schmied BM, Ringel J, Friess H, Hollingsworth MA, Buchler MW, Aubert JP, Batra SK. Mucin (MUC) gene expression in human pancreatic adenocarcinoma andchronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clin Cancer Res. 2001;7:12.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Swartz MJ, Batra SK, Varshney GC, Hollingsworth MA, Yeo CJ, Cameron JL, Wilentz RE, Hruban RH, Argani P. MUC4 expression increases progres-sively in pancreatic intraepithelial neoplasia. Am J Clin Pathol. 2002;117:5.</td><td><a href=http://dx.doi.org/10.1309/7Y7N-M1WM-R0YK-M2VA>10.1309/7Y7N-M1WM-R0YK-M2VA</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Moniaux N, Escande F, Batra SK, Porchet N, Laine A, Aubert JP. Alternative splicing generates a family of putative secreted and membrane-associated MUC4 mucins. Eur JBiochem. 2000;267:14.</td><td><a href=http://dx.doi.org/10.1046/j.1432-1327.2000.01504.x>10.1046/j.1432-1327.2000.01504.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Baruch A, Hartmann M, Yoeli M, Adereth Y, Greenstein S, Stadler Y, Skornik Y, Zaretsky J, Smorodinsky NI, Keydar I, Wreschner DH. The breast cancer-associated MUC1 gene generates both a receptor and its cognate binding protein. Cancer Res. 1999;59:7.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Baruch A, Hartmann M, Zrihan-Licht S, Greenstein S, Burstein M, Keydar I, Weiss M, Smorodinsky N, Wreschner DH. Preferential expression of novel MUC1 tumor antigen isoforms in human epithelial tumors and their tumor-potentiating function. Int J Cancer. 1997;71:5.</td><td><a href=http://dx.doi.org/10.1002/(SICI)1097-0215(19970529)71:5&lt;741::AID-IJC9&gt;3.0.CO;2-R>10.1002/(SICI)1097-0215(19970529)71:5&lt;741::AID-IJC9&gt;3.0.CO;2-R</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Xie K, Zhi X, Tang J, Zhu Y, Zhang J, Li Z, Tao J, Xu Z. Upregulation of the splice variant MUC4/Y in the pancreatic cancer cell line MIA PaCa-2 potentiates proliferation and suppresses apoptosis: new insight into the presence of the transcript variant of MUC4. Oncol Rep. 2014;31:5.</td><td><a href=http://dx.doi.org/10.3892/or.2014.3113>10.3892/or.2014.3113</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, ArticleTitle, Author_FamilyName_2, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Zhu Y, Zhang JJ, Xie KL, Tang J, Liang WB, Zhu R, Wang B, Tao JQ, Zhi XF, Li Z, Gao WT, Jiang KR, Miao Y, Xu ZK. Specific-detection of clinical samples, systematic functional investigations, and transcriptome analysis reveals that splice variant MUC4/Y contributes to the malignant progression of pancreatic cancer by triggering malignancy-related positive feedback loops signaling. J Transl Med. 2014;12:1.</td><td><a href=http://dx.doi.org/10.1186/1479-5876-12-1>10.1186/1479-5876-12-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Rossi</span> <span style='background:#DDDDDD'>V</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Beffagna</span> <span style='background:#DDDDDD'>G</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Rampazzo</span> <span style='background:#DDDDDD'>A</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Bauce</span> <span style='background:#DDDDDD'>B</span></span>, and <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Danieli</span> <span style='background:#DDDDDD'>GA</span></span></aug>. <span style='background:#CCCCFF'>TAIL1: an isthmin-like gene, containing type 1 thrombospondin-repeat and AMOP domain, mapped to ARVD1 critical region</span>. <span style='background:#CCFF99'>Gene</span>. <span style='background:#66FF66'>2004</span>;<span style='background:#FFCC66'>23</span>:<span style='background:#D279FF'>335</span>.</td><td><a href=http://dx.doi.org/10.1016/j.gene.2004.03.008>10.1016/j.gene.2004.03.008</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, Author_FamilyName_2, Author_FamilyName_1, JournalTitle, Year</td><td>CrossRef</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Ciccarelli FD, Doerks T, Bork P. AMOP, a protein module alternatively spliced in cancer cells. TRENDS in Biochemical Sciences. 2002;27:3.</td><td><a href=http://dx.doi.org/10.1016/S0968-0004(01)02036-9>10.1016/S0968-0004(01)02036-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Osorio L, Wu X, Zhou Z. Distinct spatiotemporal expression of ISM1 during mouse and chick development. Cell Cycle. 2014;13:10.</td><td><a href=http://dx.doi.org/10.4161/cc.28494>10.4161/cc.28494</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Gao W, Sweeney C, Walsh C, Rooney P, McCormick J, Veale DJ, Fearon U. Notch signalling pathways mediate synovial angiogenesis in response to vascular endothelial growth factor and angiopoietin 2. Ann Rheum Dis. 2013;72:6.</td><td><a href=http://dx.doi.org/10.1136/annrheumdis-2012-201978>10.1136/annrheumdis-2012-201978</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Rachagani S, Macha MA, Ponnusamy MP, Haridas D, Kaur S, Jain M, Batra SK. MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1. Carcinogenesis. 2012;33:10.</td><td><a href=http://dx.doi.org/10.1093/carcin/bgs225>10.1093/carcin/bgs225</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Wang Z, Banerjee S, Li Y, Rahman KM, Zhang Y, Sarkar FH. Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res. 2006;66:5.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Wang F, Zhou H, Xia X, Sun Q, Wang Y, Cheng B. Activated Notch signaling is required for hepatitis B virus X protein to promote proliferation and survival of human hepatic cells. Cancer Lett. 2010;298:1.</td><td><a href=http://dx.doi.org/10.1016/j.canlet.2010.08.009>10.1016/j.canlet.2010.08.009</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR34</td><td>BibArticle</td><td>Chaturvedi P, Singh AP, Chakraborty S, Chauhan SC, Bafna S, Meza JL, Singh PK, Hollingsworth MA, Mehta PP, Batra SK. MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells. Cancer Res. 2008;68:7.</td><td><a href=http://dx.doi.org/10.1158/0008-5472.CAN-07-6041>10.1158/0008-5472.CAN-07-6041</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR35</td><td>BibArticle</td><td>Kaur S, Sharma N, Krishn SR, Lakshmanan I, Rachagani S, Baine MJ, Smith LM, Lele SM, Sasson AR, Guha S, Mallya K, Anderson JM, Hollingsworth MA and Batra SK. MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-kappaBsignaling in pancreatic cancer. Clin Cancer Res. 2014;20:3.</td><td><a href=http://dx.doi.org/10.1158/1078-0432.CCR-13-2174>10.1158/1078-0432.CCR-13-2174</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR36</td><td>BibArticle</td><td>Senapati S, Gnanapragassam VS, Moniaux N, Momi N, Batra SK. Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells. Oncogene. 2012;31:28.</td><td><a href=http://dx.doi.org/10.1038/onc.2011.505>10.1038/onc.2011.505</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR37</td><td>BibArticle</td><td>Komatsu M, Tatum L, Altman NH, Carothers Carraway CA, Carraway KL. Potentiation of metastasis by cell surface sialomucin complex (rat MUC4), a multifunctional anti-adhesive glycoprotein. Int J Cancer. 2000;87:4.</td><td><a href=http://dx.doi.org/10.1002/1097-0215(20000815)87:4&lt;480::AID-IJC4&gt;3.0.CO;2-6>10.1002/1097-0215(20000815)87:4&lt;480::AID-IJC4&gt;3.0.CO;2-6</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR38</td><td>BibArticle</td><td>Moniaux N, Chaturvedi P, Varshney GC, Meza JL, Rodriguez-Sierra JF, Aubert JP, Batra SK. Human MUC4 mucin induces ultra-structural changes and tumorigenicity in pancreatic cancer cells. Br J Cancer. 2007;97:3.</td><td><a href=http://dx.doi.org/10.1038/sj.bjc.6603868>10.1038/sj.bjc.6603868</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR39</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Artavanis-Tsakonas</span> <span style='background:#DDDDDD'>S</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Muskavitch</span> <span style='background:#DDDDDD'>MA</span></span></aug>. <span style='background:#CCCCFF'>Notch: the past, the present, and the future</span>. <span style='background:#CCFF99'>Curr Top Dev Biol</span>. <span style='background:#66FF66'>2010</span>. doi:<span style='background:#CFBFB1'>10.1016/S0070-2153:10</span>.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1016/S0070-2153(10)92001-2>10.1016/S0070-2153(10)92001-2</a></td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, Author_FamilyName_2, Year</td><td>CrossRef</td></tr><tr><td>CR40</td><td>BibArticle</td><td>Yabuuchi S, Pai SG, Campbell NR, de Wilde RF, De Oliveira E, Korangath P, Streppel MM, Rasheed ZA, Hidalgo M, Maitra A, Rajeshkumar NV. Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer. Cancer Lett. 2013;335:1.</td><td><a href=http://dx.doi.org/10.1016/j.canlet.2013.01.054>10.1016/j.canlet.2013.01.054</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR41</td><td>BibArticle</td><td>Hu L, Xue F, Shao M, Deng A, Wei G. Aberrant expression of Notch3 predicts poor survival for hepatocellular carcinomas. Biosci Trends. 2013;7:3.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.5582/bst.2013.v7.3.152>10.5582/bst.2013.v7.3.152</a></td><td><b>CrossRef-Web</b></td>
<td>JournalTitle, ArticleTitle, Year</td><td>CrossRef</td></tr><tr><td>CR42</td><td>BibArticle</td><td>Zhang Q, Lu C, Fang T, Wang Y, Hu W, Qiao J, Liu B, Liu J, Chen N, Li M, Zhu R. Notch3 functions as a regulator of cell self-renewal by interacting with the beta-catenin pathway in hepatocellular carcinoma. Oncotarget. 2015;6:6.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR43</td><td>BibArticle</td><td>Zhang H, Teng X, Liu Z, Zhang L, Liu Z, Fernandez-Marcos PJ, Serrano M, Maraver A. Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis. J Exp Clin Cancer Res. 2015;12:34.</td><td><a href=http://dx.doi.org/10.1186/s13046-015-0132-y>10.1186/s13046-015-0132-y</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>JournalTitle, Year, ArticleTitle, Author_FamilyName_1, Author_FamilyName_2</td><td>CrossRef</td></tr><tr><td>CR44</td><td>BibArticle</td><td>Wang Z, Zhang Y, Li Y, Banerjee S, Liao J, Sarkar FH. Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Mol Cancer Ther. 2006;5:3.</td><td><a href=http://dx.doi.org/10.1186/1476-4598-5-3>10.1186/1476-4598-5-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR45</td><td>BibArticle</td><td>Liu H, Zhang W, Kennard S, Caldwell RB, Lilly B. Notch3 is critical for proper angiogenesis and mural cell investment. Circ Res. 2010;107:7.</td><td><a href=http://dx.doi.org/10.1161/CIRCRESAHA.110.218271>10.1161/CIRCRESAHA.110.218271</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, VolumeID, ArticleTitle, Author_FamilyName_1, Author_FamilyName_2</td><td>CrossRef</td></tr><tr><td>CR46</td><td>BibArticle</td><td>Wang Z, Kong D, Banerjee S, Li Y, Adsay NV, Abbruzzese J, Sarkar FH. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaBsignaling. Cancer Res. 2007;67:23.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR47</td><td>BibArticle</td><td>Buchler P, Gazdhar A, Schubert M, Giese N, Reber HA, Hines OJ, Giese T, Ceyhan GO, Muller M, Buchler MW, Friess H. The Notch signaling pathway is related to neurovascular progression of pancreatic cancer. Ann Surg. 2005;242:6.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR48</td><td>BibArticle</td><td>Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:6.</td><td><a href=http://dx.doi.org/10.1038/nm0603-669>10.1038/nm0603-669</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, VolumeID, ArticleTitle, Author_FamilyName_1, Author_FamilyName_2</td><td>CrossRef</td></tr><tr><td>CR49</td><td>BibArticle</td><td>Zhang J, Zhu L, Fang J, Ge Z, Li X. LRG1 modulates epithelial-mesenchymal transition and angiogenesis in colorectal cancer via HIF-1&#945; activation. J Exp Clin Cancer Res. 2016;35:29.</td><td><a href=http://dx.doi.org/10.1186/s13046-016-0306-2>10.1186/s13046-016-0306-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR50</td><td>BibArticle</td><td>Ge G, Wang A, Yang J, Chen Y, Yang J, Li Y, Xue Y. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cance. J Exp Clin Cancer Res. 2016;20:35.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR51</td><td>BibArticle</td><td>Wey JS, Fan F, Gray MJ, Bauer TW, McCarty MF, Somcio R, Liu W, Evans DB, Wu Y, Hicklin DJ, Ellis LM. Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines. Cancer. 2005;104:2.</td><td><a href=http://dx.doi.org/10.1002/cncr.21145>10.1002/cncr.21145</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR52</td><td>BibArticle</td><td>Giordano G, Febbraro A, Tomaselli E, Sarnicola ML, Parcesepe P, Parente D, Forte N, Fabozzi A, Remo A, Bonetti A, Manfrin E, Ghasemi S, Ceccarelli M, Cerulo L, Bazzoni F, Pancione M. Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer. J Exp Clin Cancer Res. 2015;1:34.</td><td><a href=http://dx.doi.org/10.1186/s13046-015-0225-7>10.1186/s13046-015-0225-7</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>JournalTitle, Year, ArticleTitle, Author_FamilyName_1, Author_FamilyName_2</td><td>CrossRef</td></tr><tr><td>CR53</td><td>BibArticle</td><td>Ding C, Luo J, Li L, Li S, Yang L, Pan H, Liu Q, Qin H, Chen C, Feng J. Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer. J Exp Clin Cancer Res. 2016;12:35.</td><td><a href=http://dx.doi.org/10.1186/s13046-015-0280-0>10.1186/s13046-015-0280-0</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, Author_FamilyName_2, Author_FamilyName_1, JournalTitle, Year</td><td>CrossRef</td></tr><tr><td>CR54</td><td>BibArticle</td><td>Mehner C, Hockla A, Miller E, Ran S, Radisky DC, Radisky ES. Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer. Oncotarget. 2014;5:9.</td><td><a href=http://dx.doi.org/10.18632/oncotarget.1932>10.18632/oncotarget.1932</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR55</td><td>BibArticle</td><td>Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature. 2000;407:6801.</td><td><a href=http://dx.doi.org/10.1038/35025215>10.1038/35025215</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR56</td><td>BibArticle</td><td>Eklund L, Saharinen P. Angiopoietin signaling in the vasculature. Exp Cell Res. 2013;319:9.</td><td><a href=http://dx.doi.org/10.1016/j.yexcr.2013.03.011>10.1016/j.yexcr.2013.03.011</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR57</td><td>BibArticle</td><td>Kishimoto K, Liu S, Tsuji T, Olson KA, Hu GF. Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene. 2005;24:3.</td><td><a href=http://dx.doi.org/10.1038/sj.onc.1208223>10.1038/sj.onc.1208223</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR58</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Tang</span> <span style='background:#DDDDDD'>KD</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Holzapfel</span> <span style='background:#DDDDDD'>BM</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Liu</span> <span style='background:#DDDDDD'>J</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Lee</span> <span style='background:#DDDDDD'>TK</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Ma</span> <span style='background:#DDDDDD'>S</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Jovanovic</span> <span style='background:#DDDDDD'>L</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>An</span> <span style='background:#DDDDDD'>J</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Russell</span> <span style='background:#DDDDDD'>PJ</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Clements</span> <span style='background:#DDDDDD'>JA</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Hutmacher</span> <span style='background:#DDDDDD'>DW</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Ling</span> <span style='background:#DDDDDD'>MT</span></span></aug>. <span style='background:#CCCCFF'>Tie-2 regulates the stemness and metastatic properties of prostate cancer cells</span>. <span style='background:#CCFF99'>Oncotarget</span>. <span style='background:#66FF66'>2015</span>. doi:<span style='background:#CFBFB1'>10.18632/oncotarget.3950</span></td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR59</td><td>BibArticle</td><td>Holash J, Wiegand SJ, Yancopoulos GD. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene. 1999;18:38.</td><td><a href=http://dx.doi.org/10.1038/sj.onc.1203035>10.1038/sj.onc.1203035</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR60</td><td>BibArticle</td><td>Tsutsui S, Inoue H, Yasuda K, Suzuki K, Takeuchi H, Nishizaki T, Higashi H, Era S and Mori M. Angiopoietin 2 expression in invasive ductal carcinoma of the breast: its relationship to the VEGF expression and microvessel density. Breast Cancer Res Treat. 2006;98:3.</td><td><a href=http://dx.doi.org/10.1007/s10549-005-9157-9>10.1007/s10549-005-9157-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>